• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Post-myocardial infarction ventricular septal defects: incidence and treatment trends during and after the COVID-19 pandemic

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Jan 2;15(1):445.
doi: 10.1038/s41598-024-84983-z. Post-myocardial infarction ventricular septal defects: incidence and treatment trends during and after the COVID-19 pandemic

Giuseppe Nasso[SUP] #[/SUP][SUP] 1 [/SUP], Ignazio Condello[SUP] 2 3 [/SUP], Walter Vignaroli[SUP] #[/SUP][SUP] 4 [/SUP], Andrea Antonazzo[SUP] 5 [/SUP], Francesco Bartolomucci[SUP] 6 [/SUP], Barbara Pala[SUP] 7 [/SUP], Claudio Larosa[SUP] 6 [/SUP], Annachiara Pingitore[SUP] 8 [/SUP], Vincenzo Amodeo[SUP] 9 [/SUP], Vincenzo Montemurro[SUP] 10 [/SUP], Mizar D'Abramo[SUP] 11 [/SUP], Roberto Ceravolo[SUP] 12 [/SUP], Domenica Donato[SUP] 5 [/SUP], Pasquale Fratto[SUP] 5 [/SUP], Maria Grazia De Rosis[SUP] 13 [/SUP], Giuseppe Diaferia[SUP] 14 [/SUP], Rita Torraco[SUP] 14 [/SUP], Gaetano Contegiacomo[SUP] 1 [/SUP], Guido Lembo[SUP] 1 [/SUP], Mario Siro Brigiani[SUP] 1 [/SUP], Giuseppe Santarpino[SUP] 1 [/SUP], Giuseppe Speziale[SUP] 1 [/SUP]



Affiliations
Abstract

Ventricular septal defect (VSD) is a serious complication of myocardial infarction (MI), with its global incidence significantly reduced in recent years due to advances in coronary reperfusion techniques. However, during the COVID-19 pandemic, there was an unexpected rise in the incidence of post-MI VSD, likely driven by delays in seeking treatment. This study retrospectively analyzed 10 cases of post-MI VSD treated at our hospitals from March 2018 to August 2023, comparing incidence rates across pre-pandemic, pandemic, and post-pandemic periods. The findings revealed a notable increase in VSD cases during the pandemic, with six cases occurring in two years, compared to only two cases in each of the pre-pandemic and post-pandemic periods. Despite these fluctuations, surgical intervention remained a crucial and effective treatment, with 60% of patients surviving the 30-day follow-up. The study underscores the impact of delayed treatment on VSD incidence during the pandemic and highlights the critical need for timely medical intervention to manage severe MI complications effectively.

Keywords: COVID-19 pandemic; Delayed treatment; Myocardial infarction; Post-MI complications; Surgical correction; Ventricular Setpal defect.

 
Back
Top Bottom